Analyst Ratings for Haemonetics Corp. (HAE)

Updated: 2017-07-27

An average rating of Hold has been given to Haemonetics Corp. (NYSE:HAE) by analysts covering the stock. About 30 days ago, HAE was issued an average rating of Hold.

9 analysts issued ratings on the stock, where 2 gave HAE a buy rating, 0 issued an overweight rating, 6 issued a hold rating, 0 gave an underweight rating, and 1 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. During this time, the number of analysts bearish on the stock has increased by 0.

HAE was given price targets by several analysts. The maximum price target given was 50, which equates to a potential upside of 26.52 percent. The most pessimistic price target was 38, which equates to a potential downside of -3.85 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

In the last 30 days, analysts have changed their quarterly earnings estimates downwards by an average of -1.56 percent. This can be compared with the average change in earnings estimates over the past 3 months, which is 0 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0.32 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -0.88 percent.

Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 0 analysts increased their quarterly estimates, while 2 analysts made negative revisions. Also over the last month, 2 analysts increased their estimates for the FY earnings, compared to 1 analysts that revised their FY estimates downwards.

In the last 52-weeks, HAE has achieved a high of 43.62 and a low of 29.75. The current market price is above the trailing year's low by 32.84 percent, and 9.4 percent lower than its 52-week high. HAE has a price/earnings ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The HAE value stock report compares HAE to some of its peers using value stock charts. The market cap of HAE is $2.08 billion. HAE will post this quarters earnings in days, on 0000-00-00.